Page 369«..1020..367368369370

Weak Kidneys Cause Weak Bones

By admin

by Jean-Claude Alix, NaturopathNo single area of the body stands alone, everything is linked up. This is why medical specialisation is one of the greatest mistakes that was evermade.Viewed from this angle, hardly any two areas are so closely and deeply intertwined as the renal metabolism and the bone metabolism. Thus, it is understandable that […]

To Read More: Weak Kidneys Cause Weak Bones
categoriaIntegrative Medicine commentoComments Off on Weak Kidneys Cause Weak Bones | dataApril 15th, 2010
Read All

3-Parent Embryos Could Prevent Disease, But Raise Ethical Issues – Wired News

By admin

Reuters3-Parent Embryos Could Prevent Disease, But Raise Ethical IssuesWired NewsThe technique is a subtle form of genetic engineering, which many people consider taboo, and raises other ethical dilemmas. It could also allow parents …Three-Parent Babies Due Soon, Thanks to ScienceFOXNewsall 145 news articles »

To Read More: 3-Parent Embryos Could Prevent Disease, But Raise Ethical Issues – Wired News
categoriaUncategorized commentoComments Off on 3-Parent Embryos Could Prevent Disease, But Raise Ethical Issues – Wired News | dataApril 15th, 2010
Read All

CORRECTED: Are regulators dropping the ball on biocrops? – Reuters

By admin

ReutersCORRECTED: Are regulators dropping the ball on biocrops?Reuters”One of the things that we think is important to do is to have regular reviews and updates of our strategies for regulating products of biotechnology,” said …Are US regulators dropping the ball when it comes to biocrops?BusinessWorld OnlineSPECIAL REPORT-Are US regulators dropping the ball on biocrops?Forexyardall 18 […]

To Read More: CORRECTED: Are regulators dropping the ball on biocrops? – Reuters
categoriaUncategorized commentoComments Off on CORRECTED: Are regulators dropping the ball on biocrops? – Reuters | dataApril 15th, 2010
Read All

F.D.A. Says Millions Got Unapproved Drugs, Should the new bioequivalence and bioanalytical guidelines for 2010, be made more stringent

By admin

Plans by  FDA to Adopt stricter standards for Bioequivalence, Bioavailability for generic drugs could sound trouble for Indian Generic Manufactures. Already most of the smaller companies are finding it difficult to get FDA approval letters. QSR Draft Guidance An industry working group has urged the FDA to consider adopting its guidance to outline quality system […]

To Read More: F.D.A. Says Millions Got Unapproved Drugs, Should the new bioequivalence and bioanalytical guidelines for 2010, be made more stringent
categoriaUncategorized commentoComments Off on F.D.A. Says Millions Got Unapproved Drugs, Should the new bioequivalence and bioanalytical guidelines for 2010, be made more stringent | dataApril 15th, 2010
Read All

East Africa: South Africa Leads in GM Crops as EA Lags Behind – AllAfrica.com

By admin

ReutersEast Africa: South Africa Leads in GM Crops as EA Lags BehindAllAfrica.comWith reduced requirements for farm inputs and increased yields per unit area, genetic engineering, a modern form of biotechnology, could transform the …Green thumbsTruth about Trade & TechnologyWeeds improve resistance to RoundupSt. Louis Post-DispatchSome weeds, bugs grew resistant to genetically engineered cropsUSA TodayEnvironment News […]

To Read More: East Africa: South Africa Leads in GM Crops as EA Lags Behind – AllAfrica.com
categoriaUncategorized commentoComments Off on East Africa: South Africa Leads in GM Crops as EA Lags Behind – AllAfrica.com | dataApril 14th, 2010
Read All

US Reps propose tougher Medicare fraud penalties – WZVN-TV

By admin

Journal Record (subscription)US Reps propose tougher Medicare fraud penaltiesWZVN-TVThe proposed bill would double prison sentences for Medicare fraud and use biotechnology such as fingerprint scanning to ensure patients are getting the …House bill would double Medicare fraud penaltiesJournal Record (subscription)all 23 news articles »

To Read More: US Reps propose tougher Medicare fraud penalties – WZVN-TV
categoriaUncategorized commentoComments Off on US Reps propose tougher Medicare fraud penalties – WZVN-TV | dataApril 14th, 2010
Read All

International Stem Cell Corporation Engages Leading Immunogeneticists to Advance its Industry-first, Immune-matched Stem Cells

By admin

International Stem Cell Corporation (OTCBB:ISCO), http://www.intlstemcell.com, today added two world-leading immunogeneticists to its scientific advisory board. They and ISCO scientists will study the immune-matching properties of ISCO’s human parthenogenetic stem cell (hpSC) technology and the potential for each hpSC-derived therapeutic cell to be an immune-match for millions of people.Dr. Hans-Dieter Volk, Professor of Immunology and […]

To Read More: International Stem Cell Corporation Engages Leading Immunogeneticists to Advance its Industry-first, Immune-matched Stem Cells
categoriaStem Cell Therapy commentoComments Off on International Stem Cell Corporation Engages Leading Immunogeneticists to Advance its Industry-first, Immune-matched Stem Cells | dataApril 14th, 2010
Read All

Law Headlines:Is it fair to patent genes? ACLU takes on biotech over issue – Legal Info Today

By admin

TopNews United StatesLaw Headlines:Is it fair to patent genes? ACLU takes on biotech over issueLegal Info TodayA successful ACLU lawsuit against the biotechnology company Myriad Genetics over the BRCA gene has some celebrating and others alarmed. …The profit strandThe AgeMaking sense of patentsABC OnlineIs it fair to patent genes? ACLU takes on biotech over issueUSA […]

To Read More: Law Headlines:Is it fair to patent genes? ACLU takes on biotech over issue – Legal Info Today
categoriaUncategorized commentoComments Off on Law Headlines:Is it fair to patent genes? ACLU takes on biotech over issue – Legal Info Today | dataApril 14th, 2010
Read All

Monoclonal Antibodies Promise New Chances For Ovarian Cancer Therapy: Research … – Pharmaceutical Business Review

By admin

Live-PR.com (press release)Monoclonal Antibodies Promise New Chances For Ovarian Cancer Therapy: Research …Pharmaceutical Business ReviewAccording to a research conducted by a group of scientists in partnership with professor Michael Krainer, director of the molecular genetics working group, …New options for the treatment of ovarian cancerPharmacy Europeall 62 news articles »

To Read More: Monoclonal Antibodies Promise New Chances For Ovarian Cancer Therapy: Research … – Pharmaceutical Business Review
categoriaUncategorized commentoComments Off on Monoclonal Antibodies Promise New Chances For Ovarian Cancer Therapy: Research … – Pharmaceutical Business Review | dataApril 14th, 2010
Read All

CSC news roundup 2010-04-11

By admin

Cancer Stem Cells: Back to Darwin? (review) [FriendFeed entry][Connotea bookmark][PubMed citation] http://bit.ly/csTyxT Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma [FriendFeed entry][PubMed citation] http://bit.ly/bwUz7C The nuclear receptor tailless induces long-term neural stem cell expansion and brain tumor initiation [FriendFeed entry][News release][PubMed citation] http://bit.ly/cCjVZL Hedgehog Signaling and Cancer Stem Cells in Hematopoietic […]

To Read More: CSC news roundup 2010-04-11
categoriaStem Cell Therapy commentoComments Off on CSC news roundup 2010-04-11 | dataApril 12th, 2010
Read All

Sunlight May Help Protect Men From Kidney Cancer

By admin

(HealthDay News) — Men with jobs that expose them to high levels of sunlight are less likely to develop kidney cancer than those with little or no sunlight exposure at work, says a new study.Previous research suggests that vitamin D, which is obtained from sun exposure and certain foods and supplements, may help prevent some […]

To Read More: Sunlight May Help Protect Men From Kidney Cancer
categoriaIntegrative Medicine commentoComments Off on Sunlight May Help Protect Men From Kidney Cancer | dataApril 10th, 2010
Read All

ProShares Launches Two New Exchange Traded Funds Based on the NASDAQ … – CNNMoney.com (press release)

By admin

ETF DatabaseProShares Launches Two New Exchange Traded Funds Based on the NASDAQ …CNNMoney.com (press release)2 ProShares Ultra Nasdaq Biotechnology (Nasdaq:BIB) aims to provide investment results that correspond to 200% of the daily performance of the NASDAQ …ProShares Launches First Leveraged and Inverse Biotechnology ETFsMarketWatch (press release)Avoid New Biotech Leveraged ETFsTheStreet.com (subscription)Double Your Biotech Returns! Really!Motley […]

To Read More: ProShares Launches Two New Exchange Traded Funds Based on the NASDAQ … – CNNMoney.com (press release)
categoriaUncategorized commentoComments Off on ProShares Launches Two New Exchange Traded Funds Based on the NASDAQ … – CNNMoney.com (press release) | dataApril 10th, 2010
Read All

Generex Biotechnology Firms About 4% on Funding Commitment – ONN.tv

By admin

BNETGenerex Biotechnology Firms About 4% on Funding CommitmentONN.tvby MidnightTrader.com April 8, 2010 11:07 EDT Related Symbols: GNBT 11:07 AM Eastern Daylight Time, 04/08/2010 (MidnightTrader) — Generex Biotechnology …Generex Receives Funding CommitmentMarketWatch (press release)Generex Receives Funding CommitmentTrading Markets (press release)all 23 news articles »

To Read More: Generex Biotechnology Firms About 4% on Funding Commitment – ONN.tv
categoriaUncategorized commentoComments Off on Generex Biotechnology Firms About 4% on Funding Commitment – ONN.tv | dataApril 10th, 2010
Read All

Trading looks for biotechs to decline – optionMONSTER Research (registration)

By admin

ETF Trends (blog)Trading looks for biotechs to declineoptionMONSTER Research (registration)Unusual option action is showing that someone is positioning for a pullback in the Nasdaq Biotechnology Index Fund. The IBB exchange-traded fund is off 0.17 …ETFs and EarningsTheStreet.com (subscription)Nine ETFs To Buy NowForbesThis Week in ETFs: April 9th EditionETF Databaseall 52 news articles »

To Read More: Trading looks for biotechs to decline – optionMONSTER Research (registration)
categoriaUncategorized commentoComments Off on Trading looks for biotechs to decline – optionMONSTER Research (registration) | dataApril 10th, 2010
Read All

US Sen. Bob Casey presents Hanover Township biotechnology company ABEC with award – The Express Times – LehighValleyLive.com

By admin

The Express Times – LehighValleyLive.comUS Sen. Bob Casey presents Hanover Township biotechnology company ABEC with awardThe Express Times – LehighValleyLive.comLocal biotechnology company ABEC received a prestigious national award Friday for its success breaking into the international marketplace. US Sen. …Bob Casey presents award to Lehigh Valley businessThe Express Times – LehighValleyLive.comSen. Bob Casey to visit […]

To Read More: US Sen. Bob Casey presents Hanover Township biotechnology company ABEC with award – The Express Times – LehighValleyLive.com
categoriaUncategorized commentoComments Off on US Sen. Bob Casey presents Hanover Township biotechnology company ABEC with award – The Express Times – LehighValleyLive.com | dataApril 10th, 2010
Read All

HIV invades through leaky cells: study – CBC.ca

By admin

India TalkiesHIV invades through leaky cells: studyCBC.caThe research was conducted in collaboration with researchers in the department of molecular genetics at the University of Toronto and the department of …New way HIV infects women discoveredOneindiaall 61 news articles »

To Read More: HIV invades through leaky cells: study – CBC.ca
categoriaUncategorized commentoComments Off on HIV invades through leaky cells: study – CBC.ca | dataApril 9th, 2010
Read All

International Stem Cell Corporation Provides Strategic Update on its Skin Care Program

By admin

OCEANSIDE, California – April 8, 2010 – International Stem Cell Corporation (ISCO.OB), http://www.internationalstemcell.com, announces today that it’s wholly owned subsidiary, Lifeline Skin Care Inc., has achieved positive results in human safety tests of its cosmetic products and is moving forward with arrangements with Cosmetic Enterprises Ltd. for the manufacture of three cosmetic products. These developments […]

To Read More: International Stem Cell Corporation Provides Strategic Update on its Skin Care Program
categoriaStem Cell Therapy commentoComments Off on International Stem Cell Corporation Provides Strategic Update on its Skin Care Program | dataApril 9th, 2010
Read All

Generex Launches $250000000 Lawsuit Against TheStreet.com and Feuerstein – MarketWatch (press release)

By admin

TheStreet.comGenerex Launches $250000000 Lawsuit Against TheStreet.com and FeuersteinMarketWatch (press release)WORCESTER, Mass., Apr 6, 2010 (GlobeNewswire via COMTEX) — Generex Biotechnology Corporation (NASDAQ:GNBT) (www.generex.com), the leader in drug delivery …Generex: What Happens in India, Stays in IndiaTheStreet.comTheStreet stands up to Generex’s bullyingEthiopian ReviewGenerex Launches $250000000 Lawsuit Against TheStreet.com and FeuersteinTrading Markets (press release)all 12 news articles »

To Read More: Generex Launches $250000000 Lawsuit Against TheStreet.com and Feuerstein – MarketWatch (press release)
categoriaUncategorized commentoComments Off on Generex Launches $250000000 Lawsuit Against TheStreet.com and Feuerstein – MarketWatch (press release) | dataApril 7th, 2010
Read All

Faulty Circuits (preview)

By admin

In most areas of medicine, doctors have historically tried to glean something about the underlying cause of a patient’s illness before figuring out a treatment that addresses the source of the problem. When it came to mental or behavioral disorders in the past, however, no physical cause was detectable so the problem was long assumed […]

To Read More: Faulty Circuits (preview)
categoriaUncategorized commentoComments Off on Faulty Circuits (preview) | dataApril 7th, 2010
Read All

Biocon buys out Cuban firm in JV, hopes to break even in 5 yrs – Business Standard

By admin

Hindu Business LineBiocon buys out Cuban firm in JV, hopes to break even in 5 yrsBusiness StandardBiocon Ltd, the Bangalore-based biotechnology company, is taking full ownership of its subsidiary, Biocon Biopharmaceuticals Pvt Ltd (BBPL) by buying the …Biocon acquires 49% Cuban partner CIMAB’s stake in JVEconomic TimesBiocon acquires stake of CIMAB in joint ventureTimes of […]

To Read More: Biocon buys out Cuban firm in JV, hopes to break even in 5 yrs – Business Standard
categoriaUncategorized commentoComments Off on Biocon buys out Cuban firm in JV, hopes to break even in 5 yrs – Business Standard | dataApril 6th, 2010
Read All